These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 39272091)
41. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis. Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638 [TBL] [Abstract][Full Text] [Related]
42. Psychosocial Barriers to Viral Suppression in a Community-based Sample of Human Immunodeficiency Virus-infected Men Who Have Sex With Men and People Who Inject Drugs in India. Prabhu S; McFall AM; Mehta SH; Srikrishnan AK; Kumar MS; Anand S; Shanmugam S; Celentano DD; Lucas GM; Solomon SS Clin Infect Dis; 2020 Jan; 70(2):304-313. PubMed ID: 30840989 [TBL] [Abstract][Full Text] [Related]
43. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs. Benedikt C; Kelly SL; Wilson D; Wilson DP; Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944 [TBL] [Abstract][Full Text] [Related]
44. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia. Meylakhs P; Aasland A; Grønningsæter A Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120 [TBL] [Abstract][Full Text] [Related]
45. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139 [TBL] [Abstract][Full Text] [Related]
46. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Childs E; Assoumou SA; Biello KB; Biancarelli DL; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Bazzi AR Harm Reduct J; 2019 Feb; 16(1):14. PubMed ID: 30744628 [TBL] [Abstract][Full Text] [Related]
47. Integrated care van delivery of evidence-based services for people who inject drugs: A cluster-randomized trial. Page KR; Weir BW; Zook K; Rosecrans A; Harris R; Grieb SM; Falade-Nwulia O; Landry M; Escobar W; Ramirez MP; Saxton RE; Clarke WA; Sherman SG; Lucas GM Addiction; 2024 Jul; 119(7):1276-1288. PubMed ID: 38561602 [TBL] [Abstract][Full Text] [Related]
48. Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study. Shelby T; Zhou X; Barber D; Altice F J Med Internet Res; 2021 Jul; 23(7):e25428. PubMed ID: 34259640 [TBL] [Abstract][Full Text] [Related]
49. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study. Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255 [TBL] [Abstract][Full Text] [Related]
50. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570 [TBL] [Abstract][Full Text] [Related]
51. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City. Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831 [TBL] [Abstract][Full Text] [Related]
52. Institutional violence from police militarization and drug cartel wars as a 'Big Event' and its influence on drug use harms and HIV risk in people who inject drugs on the U.S.-Mexico border. Lechuga J; Ramos R; Dickson-Gomez J; Beachy S; Perez G; Nevola O; Varela A; Ramos ME; Sauceda J; Ludwig-Barrron N; Salazar J Int J Drug Policy; 2023 Sep; 119():104125. PubMed ID: 37499305 [TBL] [Abstract][Full Text] [Related]
53. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique. Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273 [TBL] [Abstract][Full Text] [Related]
54. High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach. Messersmith LJ; Adjei R; Beard J; Bazzi AR; Earlywine JJ; Darko E; Agyarko-Poku T; Asafo MK; Bempah SA; Adu-Sarkodie Y Harm Reduct J; 2021 Jun; 18(1):62. PubMed ID: 34112187 [TBL] [Abstract][Full Text] [Related]
55. Access to HIV treatment and care for people who inject drugs in Kenya: a short report. Guise A; Rhodes T; Ndimbii J; Ayon S; Nnaji O AIDS Care; 2016 Dec; 28(12):1595-1599. PubMed ID: 27267309 [TBL] [Abstract][Full Text] [Related]
56. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374 [TBL] [Abstract][Full Text] [Related]
57. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs. Tookes HE; Bartholomew TS; Suarez E; Ekowo E; Ginoza M; Forrest DW; Serota DP; Rodriguez A; Kolber MA; Feaster DJ; Mooss A; Boyd D; Sternberg C; Metsch LR Drug Alcohol Depend; 2021 Dec; 229(Pt A):109124. PubMed ID: 34781096 [TBL] [Abstract][Full Text] [Related]
58. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867 [TBL] [Abstract][Full Text] [Related]
59. Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States. Wejnert C; Hess KL; Hall HI; Van Handel M; Hayes D; Fulton P; An Q; Koenig LJ; Prejean J; Valleroy LA MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1336-1342. PubMed ID: 27906906 [TBL] [Abstract][Full Text] [Related]
60. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan. Latypov A; Otiashvili D; Zule W Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]